Charles Hammons

Charles Hammons serves as a key procurement lead within the W40M MRC0 West agency under the Department of the Army, responsible for securing critical medical readiness capabilities essential to operational field medicine. He manages the acquisition of in-vitro diagnostic substances, surgical instrumentation, sterilization systems, and blood management solutions that enable high-acuity care in deployed environments. His work directly supports the agency’s mission to ensure medical sovereignty through timely, compliant procurement of mission-critical medical technologies, aligning acquisitions with DoD standards for performance, interoperability, and logistical sustainability. Hammons maintains strategic relationships with leading medical technology providers including Roche Diagnostics Corporation, Abbott Molecular Inc., Cardinal Health 414, LLC, Surgical Neuromonitoring Associates, Inc., and Premier Shockwave, Inc. These partnerships reflect a preference for established vendors with proven track records in military-grade diagnostics, neuro-monitoring, and sterile supply chain solutions. His contracting approach emphasizes technical validation, supply chain resilience, and compliance with FDA and DoD medical device regulations, fostering long-term vendor collaboration grounded in performance-based requirements. His procurement portfolio demonstrates a strong orientation toward open competition, with 77.8% of awards issued without set-aside designations. The remaining 22.2% are allocated to HUBZone and total small business set-asides under FAR 19.5, reflecting a measured commitment to socioeconomic programs without compromising mission-critical capability timelines or technical rigor. Hammons’ primary NAICS focus includes 811210 for precision equipment maintenance, 621511 for medical laboratory services, 621340 for therapeutic and audiologic services, 812332 for industrial laundering, and 325412 for pharmaceutical preparation. This reflects deep expertise in procuring diagnostic, sterilization, and point-of-care medical systems, with technical oversight spanning laboratory automation, surgical instrument reprocessing, and molecular diagnostics—ensuring field-deployable medical readiness across the combat health system.